Effects of Weight Loss on Glutathione Peroxidase 3 Serum Concentrations and Adipose Tissue Expression in Human Obesity

• Main Authors: Julia Langhardt, Gesine Flehmig, Nora Klöting, Stefanie Lehmann, Thomas Ebert, Matthias Kern, Michael R. Schön, Daniel Gärtner, Tobias Lohmann, Miriam Dressler, Mathias Fasshauer, Peter Kovacs, Michael Stumvoll, Arne Dietrich, Matthias Blüher
• Format: Article
• Language: English
• Published: Karger Publishers 2018-12-01
• Series: Obesity Facts
• Subjects: Glutathione peroxidase 3 (GPX3); Obesity; Adipose tissue; Insulin resistance; Adipokines
• Online Access: https://www.karger.com/Article/FullText/494295

Background/Aims: Altered expression and circulating levels of glutathione peroxidase 3 (GPX3) have been observed in obesity and type 2 diabetes (T2D) across species. Here, we investigate whether GPX3 serum concentrations and adipose tissue (AT) GPX3 mRNA expression are related to obesity and weight loss. Methods: GPX3 serum concentration was measured in 630 individuals, including a subgroup (n = 293) for which omental and subcutaneous (SC) GPX3 mRNA expression has been analyzed. GPX3 analyses include three interventions: 6 months after bariatric surgery (n = 80) or combined exercise/hypocaloric diet (n = 20) or two-step bariatric surgery (n = 24) studies. Results: Bariatric surgery-induced weight loss (–25.8 ± 8.4%), but not a moderate weight reduction of –8.8 ± 6.5% was associated with significantly reduced GPX3 serum concentrations. GPX3 mRNA is significantly higher expressed in AT from individuals with normal glucose metabolism compared to T2D patients. SC AT GPX3 expression is significantly higher in lean compared to obese as well as in insulin-sensitive compared insulin-resistant individuals with obesity. Weight loss after bariatric surgery causes a significant increase in SC AT GPX3 expression. AT GPX3 expression significantly correlates with age, BMI, fat distribution, insulin sensitivity (only SC AT), but not with circulating GPX3. Conclusion: Our data support the notion that SC AT GPX3 expression is associated with obesity, fat distribution and related to whole body insulin resistance.